BPG is committed to discovery and dissemination of knowledge
Citation
Wei FF, Zhang J, Jia Z, Yao ZC, Chen CQ. Furmonertinib re-challenge for epidermal growth factor receptor-mutant lung adenocarcinoma after osimertinib-induced interstitial lung disease: A case report. World J Clin Oncol 2025; 16(3): 101766 [PMID: 40130059 DOI: 10.5306/wjco.v16.i3.101766]
Please LOGIN to submit a new comment.